from large and expensive trials have been disappointing. One explanation for the poor clinical effect of aspirin is that, at normal doses, it blocks the formation of PGI, as well as TxA,. Thus, the potential antithrombotic benefits of PGI, are eliminated. Consequently, attempts have been made to develop selective inhibitors of thromboxane synthesis which have the potential of redirecting prostaglandin endoperoxide metabolism to increased formation of PGI,. However, even these compounds (e.g Dazoxiben ; see Tyler, I 983) have provided insignificant clinical benefit in thrombotic disorders (e.g. Rustin et al. 1983 ).
Dietary man2pulation of TxA,: PGI, EPA is a poor substrate for the fatty acid cyclo-oxygenase and therefore the endoperoxides PGG, and PGH, are formed in low yield (Van Dorp, 1967; Needleman et al. I 976). However, the endoperoxides themselves are efficiently converted by thromboxane synthetase and prostacyclin synthetase to TxA, and A'7 prostacyclin respectively (Smith et al. 1979). It has been reported that whereas A17 prostacyclin has an anti-aggregatory activity comparable to that of PGI, itself, TxA, was not pro-aggregatory (Needleman et al. 1979; Gryglewski et al. 1979) . This led to speculation that supplementation of the diet with EPA could lead to a reduced thrombotic tendency (Dyerberg et al. I 978). Indeed, epidemiological studies support this concept: several communities who consume a high amount of EPA in their diet, such as Greenland Eskimos and inhabitants of Japanese fishing villages, have a reduced incidence of thrombo-embolic episodes compared with age-and sex-matched control populations (Dyerberg & Bang, 1979; Hirai et al. 1980 ). Supplementation of a normal diet with fish, cod-liver oil or purified EPA leads to decreased platelet aggregability and increased bleeding times (Seiss et al. 1980; Terano et al. 1983 ); these changes are considered to reflect an antithrombotic effect.
Subsequent studies have indicated that TxA, is pro-aggregatory for platelets but it is not as potent as TxA, and the aggregation is reversible (Gryglewski et al.
Although EPA is a poor substrate for the cyclo-oxygenase it does competitively inhibit metabolism of AA and this is the most likely mechanism for the antithrombotic properties of EPA: decreased synthesis of TxA, (measured as TxB,) has been observed following increased intake of EPA in the diet. In fact, doubts were raised as to the formation of trienoic prostanoids in vivo after feeding EPA-rich diets; however, recent studies in animals and humans have confirmed that both TxA, and Al'-prostacyclin can be formed (Hamberg, 1980 
'979).

Role of leukocytes in myocardial infarction
So far the discussion has centred on platelets being the major blood cell involved in thrombotic events but the role of polymorphonuclear leukocytes (PMN) should also be considered. In an animal model of myocardial infarction it was observed that PMN accumulated in the area of infarction. The infarct was induced in anaesthetized dogs by occluding the left anterior descending coronary artery for I h followed by reperfusion for periods up to 5 h (Mullane et al. 1984) . Initially, the leukocytes adhered to the vascular endothelium and later it was observed that these cells had migrated into the sub-endothelium. It was suggested that the PMN contributed to the tissue damage in the infarct by releasing lysosomal enzymes and toxic oxygen radicals. Consequently, inhibition of PMN influx into the heart would reduce tissue damage. Indeed, hydroxyurea and an experimental compound, BW755C, both reduced PMN accumulation in the infarct and this correlated with a reduction in the area of the infarction (Mullane et al. 1984) .
It is now known that AA is not only converted by the fatty acid cyclo-oxygenase to prostanoids but it also serves as a substrate for lipoxygenases. Some metabolites formed via the latter enzymes have leukotactic properties, i.e they induce movement of leukocytes along the concentration gradient of the compound. In an early report, Turner et al. (1975) demonstrated that 12-hydroxy-eicosatetraenoic acid ( IZ-HETE), which is formed from AA by the action of a 12'-lipoxygenase, is a leukotactic agent. In the model of myocardial infarction described previously, it was demonstrated that infarcted tissue synthesized significantly more IZ-HETE than non-infarcted myocardium and this increase correlated with the infiltration of PMN (Mullane et al. 1984) . It was established that IZ-HETE was a major product of AA metabolism in dog PMN. Thus, although IZ-HETE was probably not the initial signal for the influx of cells, it is possible that the synthesis of this leukotactic principle by the PMN in the infarcted tissue amplified the response.
Myocardial infarction has several similarities to acute inflammation: (I) release of chemical mediators, (2) cellular infiltration, (3) oedema, (4) pain and (5) loss of function. Therefore, although the following sections will concentrate on inflammation, the discussion is also relevant to myocardial infarction.
Formation and biological activities of leukotriene B ,
Although IZ-HETE is an active leukotactic agent, another product of AA metabolism, leukotriene B, (LTB,), is more potent in vitro and in vivo (see Bray, 1983) . LTB, is formed from AA via the 5'-lipoxygenase in leukocytes; initially AA is converted to 5-hydroperoxy-eicosatetraenoic acid (5-HPETE) which is successively transformed to an unstable epoxide, LTA,, and then to LTB, (see Samuelsson, 1983) . Since LTB, may be an important mediator of cell infiltration occurring in inflammation, the pharmaceutical industry is actively engaged in research designed to inhibit its synthesis; however, it is possible that this goal can be achieved by nutritional means.
Dietary manipulation of leukotriene synthesis
Although EPA is a poor substrate for the fatty acid cyclo-oxygenase, it is metabolized efficiently by lipoxygenases and pentaene leukotrienes can be formed (Nugteren, 1975; Jakschik et al. 1980) . However, in several in vitro and in vivo tests, LTB, was considerably less active at affecting neutrophil function compared with LTB, (Terano et al. 1984~ ).
Synthesis of LTB, by leukocytes increased after giving rats a diet supplemented with EPA-ethyl ester (240 mg EPA/kg per d) for 4 weeks (Terano et al. 1984b ). This feeding protocol also decreased the formation of LTB,. There was a good correlation between the ratio, LTB,: LTB, synthesis by leukocytes with EPA: AA in leukocyte phospholipids (Terano et al. 1984b) .
If LTB, is an important mediator of cell infiltration occurring in inflammation, then the previously-mentioned findings suggest that EPA could be beneficial in the prevention or treatment of chronic inflammation, or both. The anti-inflammatory effects of EPA have been studied in two models of inflammation (Terano et (11. 1985) . First, the concentrations of PGE,, TxB, and LTB, and the number of leukocytes in inflammatory exudates induced by implanting carrageenin-impregnated sponges subcutaneously were determined in rats given a normal diet and in rats provided with an EPA-rich diet (feeding regime described previously). The EPA-supplementation significantly reduced the synthesis of both PGE, and TxB,; the concentration of LTB, and the number of leukocytes were also lowered but not significantly. Second, swelling was measured as an index of oedema formation after injection of carrageenin ( 2 0 g/l) into rat paws; supplementation of the diet with EPA significantly reduced the oedema relative to the control animals which is probably explained by lower synthesis of PGE, (Terano et al. 1985) .
Thus, an EPA-enriched diet may reduce the severity of inflammatory reactions by decreasing the synthesis of dienoic prostanoids and tetraenoic leukotrienes. Also, EPA promotes the formation of LTB, which is considerably less biologically active than LTB, and may antagonize the pro-inflammatory action of LTB,. However, this nutritional approach to anti-inflammatory therapy must be considered carefully because some AA metabolites may have anti-inflammatory effects. For example, PGE, has been shown to be an immunosuppressant and therefore reduction of its synthesis could produce a greater inflammatory response. Indeed, this is probably the mechanism by which an EPA-rich diet increased the incidence of collagen-induced arthritis in rats (Prickett et al. 1984) . The anti-inflammatory benefits, or otherwise, of supplementing the diet with EPA will only be clarified by conducting well-controlled clinical trials. In general, an altered dietary intake of EPA can be expected to act in a long-term manner suited to preventative or prophylactic approaches rather than the short-term activity usually associated with pharmaceutical agents. Thus, experiments in animal models of human disease, which are necessarily compressed into a short time-scale, are probably inadequate for assessing the beneficial effect of EPA.
